Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

Several states have reached a $7 billion settlement with Purdue Pharma based on the Sackler family's role in creating the opioid crisis, New York Attorney General Letitia James announced today.

(Bloomberg) -- Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the ...

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying ...

It includes the company's owners, members of the Sackler family ... Under this new deal, the Sacklers and Purdue Pharma actually agreed to pay more - about $500 million more - than under the ...

Purdue Pharma and its controlling Sackler family have offered a new settlement to resolve lawsuits over their involvement in the opioid epidemic, raising the payout from the Sacklers to $6 billion.

Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's opioid epidemic, writes Adam Maguire.

Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of lawsuits claiming they played a role in driving the opioid addiction ...

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, represents ...

Purdue, under the leadership of the Sackler families, invented, manufactured and aggressively marketed opioid products for decades, according to the lawsuits. States and cities across the country ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an ...

The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...